ABIONYX PHARMA SA (ABNX.PA) Stock Cash Flow
EPA:ABNX - Euronext Paris - Matif - FR0012616852 - Common Stock - Currency: EUR
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -3.36M | -3.52M | -4.21M | -5.82M | -1.89M | |||
| Depreciation Amortization | 151.00K | 153.00K | 135.00K | 119.00K | 22.00K | |||
| Change In Working Capital | 674.00K | 538.00K | 97.00K | -1.74M | 2.13M | |||
| Other non cash items | -500.00K | -871.00K | 615.00K | 755.00K | -865.00K | |||
| OPERATING CASH FLOW | -3.03M | -3.70M | -3.36M | -6.69M | -599.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -86.00K | -130.00K | -175.00K | -166.00K | -148.00K | |||
| Other Investing Activity | N/A | N/A | -200.00K | 1.50M | 23.00K | |||
| INVESTING CASH FLOW | -86.00K | -130.00K | -175.00K | 1.34M | -125.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.03M | -300.00K | -236.00K | -19.00K | -200.00K | |||
| Stock Issued/Repurchased | 7.52M | 4.19M | 42.00K | 3.99M | 1.75M | |||
| Other Financing Activity | N/A | N/A | -200.00K | N/A | N/A | |||
| FINANCING CASH FLOW | 6.50M | 3.89M | -194.00K | 3.97M | 1.55M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 0.00 | |||
| CHANGE IN CASH | 3.38M | 58.00K | -3.73M | -1.38M | 823.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -3.03M | -3.70M | -3.36M | -6.69M | -599.00K | |||
| Capital Expenditure | -86.00K | -130.00K | -175.00K | -166.00K | -148.00K | |||
| FREE CASH FLOW | -3.12M | -3.83M | -3.53M | -6.86M | -747.00K | |||
All data in EUR